Who owns Olema Oncology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OLMA from SEC Form 13F filings across 179 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 179 institutions disclosed 102.1M shares of Olema Oncology, Inc. worth $880.0M — about 101% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
179
13F holders
$880.0M
value, 2026 filers
101%
of shares outstanding (102.1M sh)
27
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of OLMA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 11.4M | $98.9M | 0.0% | 11.3% | -5.7% |
| 2 | Paradigm Biocapital Advisors LP | 8.7M | $75.3M | 1.5% | 8.6% | +0.6% |
| 3 | BlackRock, Inc. | 7.2M | $62.0M | 0.0% | 7.1% | +6.9% |
| 4 | Bain Capital Life Sciences Investors, LLC | 7.1M | $61.2M | 4.1% | 7% | 0.0% |
| 5 | Janus Henderson Group Ltd.NEW | 6.3M | $54.6M | 0.0% | 6.2% | new |
| 6 | BVF INC/IL | 5.3M | $45.8M | 1.5% | 5.2% | 0.0% |
| 7 | Siren, L.L.C. | 4.9M | $42.0M | 1.0% | 4.8% | 0.0% |
| 8 | STATE STREET CORP | 3.8M | $33.2M | 0.0% | 3.8% | -10.9% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 3.5M | $30.4M | 0.0% | 3.5% | +5.1% |
| 10 | Logos Global Management LP | 3.2M | $27.7M | 1.5% | 3.2% | 0.0% |
| 11 | MORGAN STANLEY | 2.4M | $20.6M | 0.0% | 2.4% | +29.8% |
| 12 | FRANKLIN TEMPLETON INC | 2.3M | $17.1M | 0.0% | 2.2% | -3.6% |
| 13 | Deep Track Capital, LP | 2.1M | $18.2M | 0.3% | 2.1% | +40.7% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 2.0M | $17.0M | 0.0% | 1.9% | +8.3% |
| 15 | Cormorant Asset Management, LP | 1.8M | $15.1M | 1.0% | 1.7% | -18.6% |
| 16 | DIMENSIONAL FUND ADVISORS LP | 1.6M | $13.4M | 0.0% | 1.5% | +9.6% |
| 17 | GOLDMAN SACHS GROUP INC | 1.5M | $12.8M | 0.0% | 1.5% | -5.3% |
| 18 | Defilade Capital Management, L.P. | 1.4M | $12.4M | 2.1% | 1.4% | +55.7% |
| 19 | LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1.4M | $11.7M | 0.6% | 1.3% | 0.0% |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $11.5M | 0.0% | 1.3% | -20.2% |
| 21 | KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.2M | $10.4M | 0.9% | 1.2% | 0.0% |
| 22 | Candriam S.C.A. | 1.2M | $10.3M | 0.0% | 1.2% | +57.7% |
| 23 | AMERIPRISE FINANCIAL INC | 1.2M | $10.0M | 0.0% | 1.1% | +37.2% |
| 24 | Duquesne Family Office LLC | 986,827 | $8.5M | 0.2% | 1% | 0.0% |
| 25 | Point72 Asset Management, L.P. | 910,579 | $7.9M | 0.0% | 0.9% | -15.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.